Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis
Status:
Recruiting
Trial end date:
2024-05-31
Target enrollment:
Participant gender:
Summary
Rheumatoid arthritis (RA) is a chronic progressive autoimmune disease with predominantly
joint involvement. To compare the efficacy and difference between elamod and tofacitib in the
treatment of rheumatoid factor-positive and negative rheumatoid arthritis in RA patients with
poor outcome after csDMARDs dosing, in order to better inform the clinical management.